Home›Articles›Why idecabtagene vicleucel needed a genetically modified immune system to workArticleWhy idecabtagene vicleucel needed a genetically modified immune system to workArticlesConnectionsSourcesComments (0)Reader Challenges (0)ConnectionsArticle OnIdecabtagene vicleucel, Drugs and Medicinal Substances Well-attested SourcesIdecabtagene vicleucel (Wikipedia)tier 2WikipediaMechanism of action, Clinical trials and Adverse effects sectionsQuote, Mechanism of action, Clinical trials and Adverse effects sectionsIt is the first cell-based gene therapy approved by the US Food and Drug Administration for the treatment of multiple myeloma.View the SourceMedicine Atlas Original Articlestier 1Comments (0)No comments yet. Be the first to share a thought.Sign in to join the discussion.Reader Challenges (0)No disputes yet. Spotted an error or a better source? Open the first one.Sign in to dispute this or suggest a correction.